Project overview:
The overarching goal of the Pediatric MRI Study and the resulting Data Repository is to foster a better
understanding of normal brain maturation as a basis for understanding
atypical brain development associated with a variety of disorders and
diseases.
This seven year study used magnetic resonance technologies to further
our knowledge of brain maturation in healthy, typically-developing infants,
children, and adolescents and to correlate brain development with cognitive
and behavioral development. The information obtained in this study is expected to
provide essential data for understanding the course of normal brain
development as a basis for understanding atypical brain development
associated with a variety of developmental, neurological, and neuropsychiatric
disorders affecting children and adults.
This study enrolled over 500 children, ranging from infancy to
young adulthood. The goal was to study each participant at least three
times over the course of the project at one of six Pediatric Centers
across the United States. Brain MR and clinical/behavioral data have
been compiled and analyzed at a Data Coordinating Center and Clinical
Coordinating Center. Additionally, MR spectroscopy and DTI data are
being analyzed.
The study was organized around two objectives corresponding to two age
ranges at the time of enrollment, each with its own protocols.
Objective 1 enrolled children
ages 4 years, 6 months through 18 years (total N = 433). This sample
was recruited across the six Pediatric Study Centers using community
based sampling to reflect the demographics of the United States in terms
of income, race, and ethnicity. The subjects were studied with both imaging
and clinical/behavioral measures at two year intervals for three time
points.

Objective 2 enrolled newborns, infants, toddlers,
and preschoolers from birth through 4 years, 5 months, who were studied
three or more times at two Pediatric Study Centers at intervals ranging
from three months for the youngest subjects to one year as the children
approach the Objective 1 age range. Both imaging and clinical/behavioral
measures were collected at each time point. Participant recruitment used
community based sampling that included hospital venues (e.g., maternity
wards and nurseries, satellite physician offices, and well-child clinics),
community organizations (e.g., day-care centers, schools, and churches),
and siblings of children participating in other research at the Pediatric
Study Centers. At timepoint 1, of those enrolled, 114 children had T1 scans that passed quality control checks.

Anatomic MRI constituted
the study's core imaging modality. Scans were attempted for all subjects
and data points. While the success rate was high, some data is missing
due to artifacts associated with child movement or poor compliance associated
with unsedated scanning, missed visits due to dental braces, and attrition
over the course of the study.
Ancillary studies included DTI and MRS, both single voxel (MRS) and MRS
imaging (MRSI). These data were collected at a subset of the Study Centers,
as shown below:
|
Pediatric Study Center
|
Objective 1
|
Objective 2
|
Single Voxel MRS(MRS)
/MRS imaging (MRSI) |
Standard DTI
|
Expanded DTI
|
| Children's Hospital Boston |
X |
X |
MRS |
X |
X |
| Cincinnati Children's Hospital Medical Center |
X |
- |
- |
X |
- |
| The University of Texas Health Science Center at Houston |
X |
- |
- |
- |
- |
| University of California, Los Angeles |
X |
- |
MRS/MRSI |
X |
- |
| The Children's Hospital of Philadelphia |
X |
- |
MRS/MRSI |
X |
X |
| Washington University in St. Louis |
X |
X |
- |
X |
X |
List of project investigators (Word Document)
Clinical/behavioral measures
included physical neurological examinations, behavioral ratings, neuropsychological
testing, structured psychiatric interviews, and hormonal measures from
urine and saliva samples.
Data release plan: The data is
being released in stages. The first data release included structural MR images
and clinical/behavioral data from the first assessments, Visit 1, for
Objective 1. A second data release included structural MRI and clinical/behavioral data from the second visit for Objective 1. A third data release will include structural MRI data for all visits for both Objective 1 and Objective 2 children. This will include some processed, as well as unprocessed, data. Additional and improved image processing is underway and may be added at a later date. Spectroscopy and diffusion tensor imaging (DTI) will be released in the future. Each data release is identified by a version number.